IDXX Relative Valuation
IDXX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IDXX is overvalued; if below, it's undervalued.
Historical Valuation
IDEXX Laboratories Inc (IDXX) is now in the Fair zone, suggesting that its current forward PE ratio of 49.36 is considered Fairly compared with the five-year average of 50.84. The fair price of IDEXX Laboratories Inc (IDXX) is between 498.43 to 765.42 according to relative valuation methord.
Relative Value
Fair Zone
498.43-765.42
Current Price：669.00
Fair
47.87
PE
1Y
3Y
5Y
Trailing
Forward
34.89
EV/EBITDA
IDEXX Laboratories Inc. (IDXX) has a current EV/EBITDA of 34.89. The 5-year average EV/EBITDA is 35.55. The thresholds are as follows: Strongly Undervalued below 18.50, Undervalued between 18.50 and 27.02, Fairly Valued between 44.07 and 27.02, Overvalued between 44.07 and 52.60, and Strongly Overvalued above 52.60. The current Forward EV/EBITDA of 34.89 falls within the Historic Trend Line -Fairly Valued range.
38.46
EV/EBIT
IDEXX Laboratories Inc. (IDXX) has a current EV/EBIT of 38.46. The 5-year average EV/EBIT is 39.71. The thresholds are as follows: Strongly Undervalued below 20.02, Undervalued between 20.02 and 29.87, Fairly Valued between 49.56 and 29.87, Overvalued between 49.56 and 59.41, and Strongly Overvalued above 59.41. The current Forward EV/EBIT of 38.46 falls within the Historic Trend Line -Fairly Valued range.
669.00
PS
IDEXX Laboratories Inc. (IDXX) has a current PS of 669.00. The 5-year average PS is 19.52. The thresholds are as follows: Strongly Undervalued below -128.85, Undervalued between -128.85 and -54.66, Fairly Valued between 93.71 and -54.66, Overvalued between 93.71 and 167.89, and Strongly Overvalued above 167.89. The current Forward PS of 669.00 falls within the Strongly Overvalued range.
44.13
P/OCF
IDEXX Laboratories Inc. (IDXX) has a current P/OCF of 44.13. The 5-year average P/OCF is 45.28. The thresholds are as follows: Strongly Undervalued below 20.80, Undervalued between 20.80 and 33.04, Fairly Valued between 57.52 and 33.04, Overvalued between 57.52 and 69.76, and Strongly Overvalued above 69.76. The current Forward P/OCF of 44.13 falls within the Historic Trend Line -Fairly Valued range.
49.62
P/FCF
IDEXX Laboratories Inc. (IDXX) has a current P/FCF of 49.62. The 5-year average P/FCF is 53.58. The thresholds are as follows: Strongly Undervalued below 24.64, Undervalued between 24.64 and 39.11, Fairly Valued between 68.05 and 39.11, Overvalued between 68.05 and 82.53, and Strongly Overvalued above 82.53. The current Forward P/FCF of 49.62 falls within the Historic Trend Line -Fairly Valued range.
IDEXX Laboratories Inc (IDXX) has a current Price-to-Book (P/B) ratio of 35.35. Compared to its 3-year average P/B ratio of 34.84 , the current P/B ratio is approximately 1.46% higher. Relative to its 5-year average P/B ratio of 48.25, the current P/B ratio is about -26.73% higher. IDEXX Laboratories Inc (IDXX) has a Forward Free Cash Flow (FCF) yield of approximately 1.75%. Compared to its 3-year average FCF yield of 1.75%, the current FCF yield is approximately 0.23% lower. Relative to its 5-year average FCF yield of 1.60% , the current FCF yield is about 9.08% lower.
34.28
P/B
Median3y
34.84
Median5y
48.25
0.02
FCF Yield
Median3y
1.75
Median5y
1.60
Competitors Valuation Multiple
The average P/S ratio for IDXX's competitors is 234.10, providing a benchmark for relative valuation. IDEXX Laboratories Inc Corp (IDXX) exhibits a P/S ratio of 669.00, which is 185.78% above the industry average. Given its robust revenue growth of 13.29%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IDXX increased by 58.62% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 37.60 to 53.09.
The secondary factor is the Revenue Growth, contributed 13.29%to the performance.
Overall, the performance of IDXX in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is IDEXX Laboratories Inc (IDXX) currently overvalued or undervalued?
What is IDEXX Laboratories Inc (IDXX) fair value?
How does IDXX's valuation metrics compare to the industry average?
What is the current P/B ratio for IDEXX Laboratories Inc (IDXX) as of Nov 18 2025?
What is the current FCF Yield for IDEXX Laboratories Inc (IDXX) as of Nov 18 2025?
What is the current Forward P/E ratio for IDEXX Laboratories Inc (IDXX) as of Nov 18 2025?